BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Djavad Mowafaghian Centre for Brain Health | DMCBH - ECPv6.2.6//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Djavad Mowafaghian Centre for Brain Health | DMCBH
X-ORIGINAL-URL:https://www.centreforbrainhealth.ca
X-WR-CALDESC:Events for Djavad Mowafaghian Centre for Brain Health | DMCBH
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230915T110000
DTEND;TZID=America/Vancouver:20230915T120000
DTSTAMP:20231124T123813
CREATED:20220706T204712Z
LAST-MODIFIED:20230901T170859Z
UID:9251-1694775600-1694779200@www.centreforbrainhealth.ca
SUMMARY:Dr. Maya Koronyo: Retinal manifestations of Alzheimer’s disease
DESCRIPTION:Zoom option if unable to attend in person:\nZoom link here (click on “Join a meeting”)\nMeeting ID: 91512 289258\nPasscode: 289258\n\nThe neural retina is a key organ for vision and visual processing. As a direct extension of the brain\, it emerges as a prominent site impacted by Alzheimer’s disease (AD).  The retina is the only CNS tissue not shielded by bone that can be easily accessible for noninvasive\, affordable\, ultra-high-resolution imaging in the clinical setting. Data from recent years strongly suggest it can serve as a window to assess AD. Early studies described retinal nerve fiber layer and ganglion cell degeneration. Our team revealed the accumulation of core AD hallmarks—amyloid β-protein (Aβ) plaques and neurofibrillary tangles—in the retina of AD and mild cognitive impairment (MCI) patients. Subsequent studies confirmed these findings\, and further reported visual and electroretinography abnormalities\, retinal tauopathy\, Aβ oligomers\, inflammation\, and cell-specific degeneration in AD patients. Data from our group and others suggest that the brain and retina follow a similar trajectory during AD progression\, potentially due to their shared embryonic origin and anatomical proximity. Moreover\, retinal vascular irregularities—vessel density and fractal dimensions\, blood flow\, foveal avascular zone\, curvature tortuosity\, arteriole-to-venule ratio—are present in AD patients\, including early-stage cases. A tight association between cerebral and retinal vasculopathy to cognitive deficits was reported in AD patients and animal models. More recently\, we identified early and progressive retinal vascular platelet-derived growth factor receptor-β (PDGFRβ) deficiency and pericyte loss\, as well as retinal endothelial tight junction losses in MCI and AD patients. These retinal vasculopathies strongly link to vascular amyloid accumulation as well as could predict the severity of cerebral amyloid angiopathy. Currently\, we explore the complex landscape of Alzheimer’s in the retina\, including AD-related molecular signatures and processes\, new forms of proteinopathies\, vascular and inflammatory abnormalities\, synaptic loss\, as well as cell-specific vulnerability and resilience. Establishing how early retinal biomarkers can be detected during AD continuum and what do they mean for brain pathology and functional decline\, should guide the development of future retinal imaging technologies to improve early\, noninvasive AD diagnosis and monitoring. \n 
URL:https://www.centreforbrainhealth.ca/events/dr-maya-koronyo/
LOCATION:Rudy North Lecture Theatre\, Djavad Mowafaghian Centre for Brain Health\, 2215 Wesbrook Mall\, Vancouver\, British Columbia\, V6T 1Z3\, Canada
CATEGORIES:Neuroscience Research Colloquium
END:VEVENT
END:VCALENDAR